Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
243 Charles St
# Retina
Boston, MA 02114Phone+1 617-391-5896
Summary
- Dr. Leo Kim is an ophthalmologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts Eye and Ear, MelroseWakefield Healthcare, Mount Auburn Hospital, Massachusetts General Hospital, and Brigham and Women's Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 12 years. He specializes in retinal disease and is experienced in retina surgery and vitreoretinal disease.
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 2006 - 2009
- Los Angeles County-Harbor-UCLA Medical CenterInternship, Internal Medicine, 2005 - 2006
- Yale School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2006 - Present
- MA State Medical License 2011 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- Targeting the Tie-2 Receptor With Faricimab in Central Serous Chorioretinopathy: A Case Series Motivated by a Genetic Finding.Joel T Rämö, Leo A Kim, Tomasz Stryjewski, Priya P Shah, Romy Bejjani
American Journal of Ophthalmology. 2025-01-01 - 1 citationsDecreased Macular Choriocapillaris Perfusion Correlates with Contrast Sensitivity Function in Dry Age-Related Macular Degeneration.Francesco Romano, Filippos Vingopoulos, Melissa Yuan, Xinyi Ding, Mauricio Garcia
Ophthalmology. Retina. 2024-12-01 - An mRNA-encoded dominant-negative inhibitor of transcription factor RUNX1 suppresses vitreoretinal disease in experimental models.Michael O'Hare, William P Miller, Said Arevalo-Alquichire, Dhanesh Amarnani, Evhy Apryani
Science Translational Medicine. 2024-11-27
Journal Articles
- Retinal Imaging Findings in Carriers with PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive SymptomsGrayson W Armstrong, Leo A Kim, Itika Garg, Megan Kasetty, JAMA Ophthalmology
Press Mentions
- Preclinical Tests Show mRNA-Based Treatments Effective for Blinding ConditionDecember 3rd, 2024
- Current Practice Preferences and Safety Protocols for Intravitreal Injection of Anti-Vascular Endothelial Growth Factor AgentsMarch 22nd, 2020
- Researchers Identify Genetic Mutation Tied to Alzheimer’s Disease ProtectionNovember 4th, 2019
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: